Pathology Services in Australia: Market Research Report

Market Research • Market Size • Industry Statistics • Industry Analysis • Industry Trends

Pathology Services Market Research Report | ANZSIC Q8521 | May 2015

There will be blood: Ageing population drives growth, but high competition brings pressure

IBISWorld’s Pathology Services market research report is a comprehensive guide to market size and growth prospects. Our industry reports offer strategic industry analysis of the factors influencing companies, including new product developments, economic, lifestyle and demographic influences, distribution and supply chain factors and pricing issues. Full analysis accompanies our data forecasts to illustrate how the market responds to emerging industry trends.

Report Snapshot
Industry Statistics & Market Size
Annual Growth 10-15
Annual Growth 15-20
Add to Cart
Add to Cart
Industry Analysis & Industry Trends

The Pathology Services industry provides vital information that helps doctors to diagnose and manage a number of diseases. Australia's ageing population and an increase in the prevalence of chronic illness are factors promoting demand for health services and referrals for pathology services. The industry derives the vast majority of its revenue from providing pathology services under Medicare. According to industry body Pathology Australia's 2015 Federal Budget submission, pathology represents 35% of all services provided under Medicare, although just 13.0% of the benefits paid. The average Medicare rebate is estimated to equal just $20.00 per service.

The industry is expected to grow by 2.3% in 2014-15, to reach $2.8 billion. Medicare is expected to record roughly 115.0... purchase to read more

Industry Report - Industry Key Buyers Chapter

The top four players currently account for 86.7% of industry revenue, indicating a particularly high concentration of ownership, although the degree of concentration varies by geographic region. The industry is expected to become more concentrated until the Australian Consumer and Competition Commission (ACCC) prevents major incumbents from any further acquisitions. Both of the two largest players have undertaken a number of acquisitions over the past five years including Sonic’s 2012 purchase of Healthscope’s Western Australian pathology business.

Australia’s largest publicly listed pathology businesses: Sonic Healthcare Ltd and Primary Health Care Ltd, together account for just over three quarters of annual industry revenue... purchase to read more


Industry ProductsRelated ReportsTable of Contents

What is the Pathology Services Industry?

Companies in this industry operate pathology laboratories and collection centres. Pathology services provided by public laboratories operating within general hospitals are excluded.

Industry Products
Chemical pathologyPatient episode initiationMicrobiologyHaematologyTissue pathologyImmunology
Industry Activities
Medical laboratory operationPathology laboratory operationPathology collection centre operation

View Sample
Select Clients